Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

BUY
$219.27 - $242.57 $196 Million - $217 Million
893,000 Added 295.89%
1,194,800 $289 Million
Q4 2021

Feb 15, 2022

SELL
$198.88 - $227.6 $457,424 - $523,480
-2,300 Reduced 0.76%
301,800 $67.9 Million
Q3 2021

Nov 16, 2021

SELL
$212.27 - $248.7 $112 Million - $131 Million
-528,500 Reduced 63.48%
304,100 $64.7 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $164 Million - $181 Million
700,000 Added 527.9%
832,600 $203 Million
Q1 2021

May 18, 2021

SELL
$221.91 - $258.6 $28.9 Million - $33.6 Million
-130,100 Reduced 49.52%
132,600 $33 Million
Q4 2020

Feb 17, 2021

SELL
$216.38 - $257.67 $24.6 Million - $29.3 Million
-113,700 Reduced 30.21%
262,700 $60.4 Million
Q3 2020

Nov 17, 2020

BUY
$234.65 - $260.95 $34.5 Million - $38.3 Million
146,900 Added 64.01%
376,400 $95.7 Million
Q2 2020

Aug 17, 2020

BUY
$197.81 - $242.74 $32.1 Million - $39.4 Million
162,300 Added 241.52%
229,500 $54.1 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $2.72 Million - $3.6 Million
14,900 Added 28.49%
67,200 $13.6 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $6.3 Million - $8.1 Million
-33,300 Reduced 38.9%
52,300 $12.6 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $3.38 Million - $4.05 Million
-19,400 Reduced 18.48%
85,600 $16.6 Million
Q2 2019

Aug 15, 2019

SELL
$166.7 - $195.41 $1.5 Million - $1.76 Million
-9,000 Reduced 7.89%
105,000 $19.4 Million
Q1 2019

May 16, 2019

BUY
$180.87 - $203.88 $4.83 Million - $5.44 Million
26,700 Added 30.58%
114,000 $21.7 Million
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $3.32 Million - $3.87 Million
18,600 Added 27.07%
87,300 $17 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $2.54 Million - $2.86 Million
13,700 Added 24.91%
68,700 $14.2 Million
Q2 2018

Aug 15, 2018

SELL
$166.05 - $186.51 $4.93 Million - $5.54 Million
-29,700 Reduced 35.06%
55,000 $10.2 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $3.3 Million - $3.86 Million
19,500 Added 29.91%
84,700 $14.4 Million
Q4 2017

Feb 15, 2018

SELL
$168.79 - $188.59 $14.8 Million - $16.6 Million
-87,900 Reduced 57.41%
65,200 $11.3 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $25.6 Million - $29.2 Million
153,100
153,100 $28.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.